Home > > Global Chemiluminescence Immunoassay Market Report
The Chemiluminescence Immunoassay market was valued at $8,791.1 Million in 2023, and is projected to reach $13,652.9 Million by 2030 growing at a CAGR of 6.55% from 2024 to 2030. Consumables segment is expected to be the highest contributor to this market, with $5,908.8 Million in 2023, and is anticipated to reach $9,015.5 Million by 2030, registering a CAGR of 6.28%. Instruments segment is anticipated to reach $3,769.3 Million by 2030 with the highest CAGR of 7.87%. Consumables and Instruments segments collectively expected to account for about 92.5% share of the Chemiluminescence Immunoassay market in 2023, with the former constituting around 67.2% share. Instruments and Consumables segments are expected to witness significant growth rates at a CAGR of 7.87% and 6.28% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 92.5% in the overall Chemiluminescence Immunoassay market in 2023, and is anticipated to reach 93.6% by 2030. Product Instruments Consumables Software & Services Application Therapeutic Drug Monitoring Oncology Cardiology Endocrinology Infectious Disease Autoimmune Disease Other Applications End-use Hospitals Clinical Laboratories Pharmaceutical & Biotechnology Companies Other End-Uses BY REGION North America U.s. Canada Europe Germany U.k. France Italy Spain Rest of Europe Asia China Japan South Korea India Singapore Rest of Asia Middle East & Africa Brazil Mexico South Africa Australia Rest of MENA